These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 31174544)
1. Regulatory T cells and M2 macrophages present diverse prognostic value in gastric cancer patients with different clinicopathologic characteristics and chemotherapy strategies. Liu X; Xu D; Huang C; Guo Y; Wang S; Zhu C; Xu J; Zhang Z; Shen Y; Zhao W; Zhao G J Transl Med; 2019 Jun; 17(1):192. PubMed ID: 31174544 [TBL] [Abstract][Full Text] [Related]
2. Prognostic perspectives of PD-L1 combined with tumor-infiltrating lymphocytes, Epstein-Barr virus, and microsatellite instability in gastric carcinomas. Choi E; Chang MS; Byeon SJ; Jin H; Jung KC; Kim H; Lee KL; Kim W; Park JH; Kim KH; Kim JS; Choi IS; Han DS; Ahn HS; Heo SC Diagn Pathol; 2020 Jun; 15(1):69. PubMed ID: 32498695 [TBL] [Abstract][Full Text] [Related]
3. Prognostic implications of immunosuppressive protein expression in tumors as well as immune cell infiltration within the tumor microenvironment in gastric cancer. Kim JW; Nam KH; Ahn SH; Park DJ; Kim HH; Kim SH; Chang H; Lee JO; Kim YJ; Lee HS; Kim JH; Bang SM; Lee JS; Lee KW Gastric Cancer; 2016 Jan; 19(1):42-52. PubMed ID: 25424150 [TBL] [Abstract][Full Text] [Related]
4. The expression of C-MYC in gastric adenocarcinoma is associated with PD-L1 and FOXP3 expression: C-MYC overexpression is a good prognostic factor. Won KY; Kim GY; Kim HK; Song MJ; Choi SI; Bae GE; Lim SJ Pathol Res Pract; 2019 Nov; 215(11):152639. PubMed ID: 31582185 [TBL] [Abstract][Full Text] [Related]
5. Gastric cancer immune microenvironment score predicts neoadjuvant chemotherapy efficacy and prognosis. Zhao S; Liu Y; Ding L; Zhang C; Ye J; Sun K; Song W; Cai S; He Y; Peng J; Xu J J Pathol Clin Res; 2024 May; 10(3):e12378. PubMed ID: 38778559 [TBL] [Abstract][Full Text] [Related]
6. Prognostic implications of tumor-infiltrating lymphocytes within the tumor microenvironment in gastric cancer. Pereira MA; Ramos MFKP; Cardili L; de Moraes RDR; Dias AR; Szor DJ; Zilberstein B; Alves VAF; de Mello ES; Ribeiro U J Gastrointest Surg; 2024 Feb; 28(2):151-157. PubMed ID: 38445936 [TBL] [Abstract][Full Text] [Related]
7. The PD-1, PD-L1 expression and CD3+ T cell infiltration in relation to outcome in advanced gastric signet-ring cell carcinoma, representing a potential biomarker for immunotherapy. Jin S; Xu B; Yu L; Fu Y; Wu H; Fan X; Wei J; Liu B Oncotarget; 2017 Jun; 8(24):38850-38862. PubMed ID: 28418918 [TBL] [Abstract][Full Text] [Related]
8. Stromal regulatory T-cells are associated with a favourable prognosis in gastric cancer of the cardia. Haas M; Dimmler A; Hohenberger W; Grabenbauer GG; Niedobitek G; Distel LV BMC Gastroenterol; 2009 Sep; 9():65. PubMed ID: 19732435 [TBL] [Abstract][Full Text] [Related]
9. Implications of NOVA1 suppression within the microenvironment of gastric cancer: association with immune cell dysregulation. Kim EK; Yoon SO; Jung WY; Lee H; Kang Y; Jang YJ; Hong SW; Choi SH; Yang WI Gastric Cancer; 2017 May; 20(3):438-447. PubMed ID: 27318497 [TBL] [Abstract][Full Text] [Related]
10. CD4/CD8 + T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosis. Li F; Sun Y; Huang J; Xu W; Liu J; Yuan Z Cancer Med; 2019 Dec; 8(17):7330-7344. PubMed ID: 31631566 [TBL] [Abstract][Full Text] [Related]
11. Association of tumor-infiltrating T lymphocytes with intestinal-type gastric cancer molecular subtypes and outcome. Mansuri N; Birkman EM; Heuser VD; Lintunen M; Ålgars A; Sundström J; Ristamäki R; Lehtinen L; Carpén O Virchows Arch; 2021 Apr; 478(4):707-717. PubMed ID: 32954467 [TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic implications of immune classification by PD-L1 expression and CD8-positive tumor-infiltrating lymphocytes in stage II and III gastric cancer patients. Koh J; Ock CY; Kim JW; Nam SK; Kwak Y; Yun S; Ahn SH; Park DJ; Kim HH; Kim WH; Lee HS Oncotarget; 2017 Apr; 8(16):26356-26367. PubMed ID: 28412752 [TBL] [Abstract][Full Text] [Related]
13. Programmed cell death ligand 1 (PD-L1) expression on gastric cancer and its relationship with clinicopathologic factors. Zhang L; Qiu M; Jin Y; Ji J; Li B; Wang X; Yan S; Xu R; Yang D Int J Clin Exp Pathol; 2015; 8(9):11084-91. PubMed ID: 26617827 [TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of immune microenvironment in laryngeal and pharyngeal squamous cell carcinoma: Immune cell subtypes, immuno-suppressive pathways and clinicopathologic characteristics. Karpathiou G; Casteillo F; Giroult JB; Forest F; Fournel P; Monaya A; Froudarakis M; Dumollard JM; Prades JM; Peoc'h M Oncotarget; 2017 Mar; 8(12):19310-19322. PubMed ID: 28038471 [TBL] [Abstract][Full Text] [Related]
15. CMA1 is potent prognostic marker and associates with immune infiltration in gastric cancer. Shi S; Ye S; Mao J; Ru Y; Lu Y; Wu X; Xu M; Zhu T; Wang Y; Chen Y; Tang X; Xi Y Autoimmunity; 2020 Jun; 53(4):210-217. PubMed ID: 32129682 [No Abstract] [Full Text] [Related]
16. Expression of PD-L1, indoleamine 2,3-dioxygenase and the immune microenvironment in gastric adenocarcinoma. Patil PA; Blakely AM; Lombardo KA; Machan JT; Miner TJ; Wang LJ; Marwaha AS; Matoso A Histopathology; 2018 Jul; 73(1):124-136. PubMed ID: 29489025 [TBL] [Abstract][Full Text] [Related]
17. Regulatory T lymphocyte infiltration in metastatic breast cancer-an independent prognostic factor that changes with tumor progression. Stenström J; Hedenfalk I; Hagerling C Breast Cancer Res; 2021 Feb; 23(1):27. PubMed ID: 33602289 [TBL] [Abstract][Full Text] [Related]
18. Low density of CD204-positive M2-type tumor-associated macrophages in Epstein-Barr virus-associated gastric cancer: a clinicopathologic study with digital image analysis. Ichimura T; Abe H; Morikawa T; Yamashita H; Ishikawa S; Ushiku T; Seto Y; Fukayama M Hum Pathol; 2016 Oct; 56():74-80. PubMed ID: 27342912 [TBL] [Abstract][Full Text] [Related]
19. Programmed death-ligand 1 expression in gastric adenocarcinoma is a poor prognostic factor in a high CD8+ tumor infiltrating lymphocytes group. Chang H; Jung WY; Kang Y; Lee H; Kim A; Kim HK; Shin BK; Kim BH Oncotarget; 2016 Dec; 7(49):80426-80434. PubMed ID: 27741514 [TBL] [Abstract][Full Text] [Related]
20. The log odds of negative lymph nodes/T stage: a new prognostic and predictive tool for resected gastric cancer patients. Xie J; Pang Y; Li X; Wu X J Cancer Res Clin Oncol; 2021 Aug; 147(8):2259-2269. PubMed ID: 34003367 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]